Anne-Marie van der Kevie-Kersemaekers
4PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 18, 2025
Long-term follow-up of MRD-guided ibrutinib plus venetoclax in relapsed CLL: phase 2 VISION/HO141 trial.Carsten U Niemann, Julie Dubois, Kazem Nasserinejad
|Jun 26, 2023
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.Lina van der Straten, Claudia A M Stege, Sabina Kersting
|May 12, 2023
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.Moritz Fürstenau, Yvonne J Thus, Sandra Robrecht
|Sep 28, 2020
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study.Arnon P Kater, Jenny Qun Wu, Thomas Kipps
Pageof 1
Frequent Collaborators
4 joint publications
Arnon P Kater
2 joint publications
Carsten Utoft Niemann
2 joint publications
Caspar da Cunha-Bang
2 joint publications
Ann Janssens
2 joint publications
Eric Eldering
1 joint publications
Lina van der Straten
1 joint publications
Claudia A M Stege
1 joint publications
Fransien de Boer
1 joint publications
John Schreurs
1 joint publications
Anton W Langerak
